RNA DUPLEX CAPABLE OF INTERFERENCE AND HAVING BLUNT ENDS AND 3'-MODIFICATIONS Russian patent published in 2010 - IPC C12N15/11 A61K48/00 

Abstract RU 2399671 C2

FIELD: medicine.

SUBSTANCE: invention refers to compounds represented by double-strained RNA mediating RNA interference and including two complementary RNA-strands containing 17-30 nucleotides with at least one blunt end which includes 3'-end of formula I: , where X means O or S, R1 and R2 independently mean OH, NH2, SH, alkyl, aryl, alkylaryl, arylalkyl, where alkyl, aril, alkylaryl, arylalkyl are optionally substituted with additional heteroatoms and functional groups where the specified heteroatom is chosen from the group including N, O and S, and the specified functional group is chosen from the group, including OH, NH2, SH, carboxylic acid and ester, or R1 and R2 can have formula Y-Z wherein Y means O, N, S, and Z means N, alkyl, aryl, alkylaryl, arylalkyl where alkyl, aryl, alkylaryl, arylalkyl are optionally substituted with additional heteroatoms where the specified heteroatom is chosen from the group including N, O and S; provided that both R1 and R2 does not mean OH.

EFFECT: offered invention allows eliminating the disadvantages of synthetic siRNA with 3'-overhanging ends.

8 cl, 4 dwg, 1 tbl, 3 ex

Similar patents RU2399671C2

Title Year Author Number
TREATMENT OF INTESTINAL DISEASES 2006
  • Gaskon Irehne
  • Khimenes Ana I.
  • Khimenes Marija Konsepsion
  • Roman Khose P.
  • Sesto Ankhela
RU2418594C2
POLYCONJUGATES FOR POLYNUCLEOTIDE INTRODUCTION IN VIVO 2007
  • Rozema Dejvid B.
  • Uehjkfild Darren Kh.
  • Uolff Dzhon A.
  • Von So
  • Klejn Dzhejson
  • Luis Dejvid L.
  • Khagstrom Dzhejms Eh.
  • Blokhin Andrej
  • Trubetskoj Vladimir
  • Kherveer Khans
RU2430740C2
SELF-DELIVERED RNAI COMPOUNDS OF REDUCED SIZE 2011
  • Khovorova Anastasia
  • Salomon William
  • Kamens Joanne
  • Samarsky Dmitry
  • Woolf Tod M.
  • Cardia James
RU2615143C2
METHOD FOR CREATION OF T-CELLS SUITABLE FOR ALLOGENEIC TRANSPLANTATION 2015
  • Puaro Loren
  • Surdive David
  • Dyushato Filipp
  • Kabanol Zhan-Perr
RU2752933C2
OLIGORIBONUCLEOTIDES AND METHODS OF THEIR APPLICATION FOR TREATMENT OF ACUTE RENAL FAILURE 2005
  • Fejnshtejn Elena
  • Zurr Deniel
  • Erlikh Shaj
RU2584609C2
OLIGIRIBONUCLEOTIDES AND METHODS OF THEIR APPLICATION FOR TREATMENT OF ACUTE RENAL FAILURE AND OTHER DISEASES 2005
  • Fejnshtejn Elena
  • Zurr Dehniel
  • Ehrlikh Shaj
RU2434942C2
HSP47 EXPRESSION MODULATION 2010
  • Tszin' Sjaomehj
  • Juj Lej
  • Takakhasi Khirokadzu
  • Tanaka Jasunobu
  • Niitsu Esiro
  • Fejnstejn Elena
  • Avkin-Nachum Sharon
  • Kalinski Khagar
  • Mett Igor'
  • Ehrlich Shaj
  • Skvajers Ehlizabet S.
  • Chen Ning
RU2575056C2
TREATMENT OF CNS DISORDERS 2007
  • Khimenes Anton Ana Izabel'
  • Sesto Jage Ankhela
  • Khimenes Gomes Marija Konseps'On
  • Gomes-Asebo Gul'On Ehduardo
RU2426544C2
MEDIATED PHKi INHIBITION OF Rho-KINASE FOR TREATING OPHTHALMIC DISORDERS 2006
  • Chatterton Dzhon E.
  • Klark Ehbbot F.
RU2432165C2
METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS OF CANCER CELLS 2003
  • Mark Nasoff
  • Kvinn L. Deveroks
  • Debora A. Kni
  • Pedro Asa-Blank
  • Garret M. Khehmpton
  • Klaus Vagner
RU2379056C2

RU 2 399 671 C2

Authors

Vajler Jan

Kholl Dzhonatan

Bolon'Ja Zhan-Sharl'

Natt Fransua Zhan-Sharl'

Khehner Robert

Dates

2010-09-20Published

2004-08-27Filed